Cargando…

The novel μ‐opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception

BACKGROUND AND PURPOSE: PZM21 is a novel μ‐opioid receptor ligand that has been reported to induce minimal arrestin recruitment and be devoid of the respiratory depressant effects characteristic of classical μ receptor ligands such as morphine. We have re‐examined the signalling profile of PZM21 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hill, Rob, Disney, Alex, Conibear, Alex, Sutcliffe, Katy, Dewey, William, Husbands, Stephen, Bailey, Chris, Kelly, Eamonn, Henderson, Graeme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003631/ https://www.ncbi.nlm.nih.gov/pubmed/29582414 http://dx.doi.org/10.1111/bph.14224

Ejemplares similares

Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation
por: Zhao, Zhennan, et al.
Publicado: (2020)

Drug Binding Poses Relate Structure with Efficacy in the μ Opioid Receptor
por: Sutcliffe, Katy J., et al.
Publicado: (2017)

The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist
por: Montes, Guilherme Carneiro, et al.
Publicado: (2017)

Molecular Modeling of µ Opioid Receptor Ligands with Various Functional Properties: PZM21, SR-17018, Morphine, and Fentanyl—Simulated Interaction Patterns Confronted with Experimental Data
por: Podlewska, Sabina, et al.
Publicado: (2020)

Role of Acetaldehyde in Ethanol Reversal of Tolerance to Morphine-Induced Respiratory Depression in Mice
por: Hill, Rob, et al.
Publicado: (2022)

A Novel G Protein–Biased Agonist at the δ Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain
por: Conibear, Alexandra E., et al.
Publicado: (2020)

μ-Opioid receptor desensitization: homologous or heterologous?
por: Llorente, Javier, et al.
Publicado: (2012)

5-Benzyl substituted 14-methoxymetopon, a high affinity μ opioid receptor agonist with potent antinociceptive activity in mice
por: Spetea, Mariana, et al.
Publicado: (2008)

Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance
por: Mosberg, Henry I., et al.
Publicado: (2014)

(-)-Pentazocine induces visceral chemical antinociception, but not thermal, mechanical, or somatic chemical antinociception, in μ-opioid receptor knockout mice
por: Ide, Soichiro, et al.
Publicado: (2011)

Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose
por: Disney, Alex, et al.
Publicado: (2022)

Synthesis, Biological, and Structural Explorations of New Zwitterionic Derivatives of 14-O-Methyloxymorphone, as Potent μ/δ Opioid Agonists and Peripherally Selective Antinociceptives
por: Spetea, Mariana, et al.
Publicado: (2018)

Negative modulation of spinal κ-opioid receptor-mediated antinociception by the µ-opioid receptor at selective doses of (−)-pentazocine
por: Robinson, Douglas L., et al.
Publicado: (2018)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
por: France, Charles P, et al.
Publicado: (2016)

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
por: Guillemyn, Karel, et al.
Publicado: (2012)

Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid Receptor
por: Cong, Xiaojing, et al.
Publicado: (2015)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Usefulness for the combination of G protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance
por: Mori, Tomohisa, et al.
Publicado: (2017)

Role of protein kinase C and μ-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons
por: Bailey, C P, et al.
Publicado: (2009)

Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?
por: Bailey, Sarah J., et al.
Publicado: (2018)

Role of μ-opioid receptor in parafascicular nucleus of thalamus on morphine-induced antinociception in a rat model of acute trigeminal pain
por: Tamaddonfard, Esmaeal, et al.
Publicado: (2017)

Structural insights into μ-opioid receptor activation
por: Huang, Weijiao, et al.
Publicado: (2015)

Modulation of G-protein activation, calcium currents and opioid receptor phosphorylation by the pH-dependent antinociceptive agonist NFEPP
por: Celik, Melih Özgür, et al.
Publicado: (2023)

The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist
por: Gassaway, M M, et al.
Publicado: (2014)

Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016)

Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020)

Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
por: Wang, Haoqing, et al.
Publicado: (2022)

Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
por: Zamora, Joshua C., et al.
Publicado: (2021)

Fumaroylamino-4,5-epoxymorphinans and Related Opioids with Irreversible μ Opioid Receptor Antagonist Effects
por: Moynihan, Humphrey A., et al.
Publicado: (2012)

Synthesis, purification, characterization, and antinociceptive activity of opioids peptides
por: Nóbrega, Mariana, et al.
Publicado: (2014)

Peripheral Antinociception Induced by Aripiprazole Is Mediated by the Opioid System
por: Ferreira, Renata Cristina Mendes, et al.
Publicado: (2017)

Role of mu opioid receptor (MOR) agonist efficacy as a determinant of opioid antinociception in a novel assay of pain-depressed behavior in female and male mice
por: Negus, S. Stevens, et al.
Publicado: (2023)

Evaluation of Antinociceptive Effects of Chitosan-Coated Liposomes Entrapping the Selective Kappa Opioid Receptor Agonist U50,488 in Mice
por: Mititelu Tartau, Liliana, et al.
Publicado: (2021)

Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch
por: Wang, Xin, et al.
Publicado: (2021)

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
por: Reichenbach, Zachary W., et al.
Publicado: (2022)

A Facile Synthesis for Novel Loperamide Analogs as Potential μ Opioid Receptor Agonists
por: Bao, Xiaofeng, et al.
Publicado: (2012)

Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors
por: Kudla, Lucja, et al.
Publicado: (2021)

The partial µ-opioid agonist buprenorphine in autism spectrum disorder: a case report
por: Skoglund, Charlotte, et al.
Publicado: (2022)

Computational Drug Design of Novel Agonists of the μ -Opioid Receptor to Inhibit Pain Signaling
por: Daoud, Nancy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_af6ja93li6u8a8gunummtrnjkf